Recorded fact · drug.trial_access

drug.trial_access for dapagliflozin

One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 7fb5e28d resolves to.

The record

Fact id	`7fb5e28dc89a618297d757a9`
Entity	drug: dapagliflozin
Field	drug.trial_access
Source	clinicaltrials.gov
Read on	2026-11-07T06:34:32.466Z
Source version	clinicaltrials-api-2.0.5-data-2026-11-06T10:00:05
Method	api
Verification	machine_read
Licence	Terms and Conditions (last updated 2023-01-31) READ in full 2026-11-07: data free to all requesters; reuse allowed on conditions: attribute ClinicalTrials.gov, keep data current, display the date the registry processed the data, state any modifications; do not represent the data as other than a US Government database; no use of extracted email addresses for marketing; some records may carry third-party copyright (consult the submitter) and the data carry an international copyright outside the US. API rate guidance page UNREAD (JS page rendered no text 2026-11-07). AMBER because of the third-party copyright caveat on submitter text; counts and ids are safe, long free text is not reproduced. \| DISPLAY CONDITIONS (any page or delivery using this source): attribute ClinicalTrials.gov, show the registry processing date, state our modifications, never present as other than a US Government database, never use extracted emails for marketing.
Edition	2026-11, Merkle root `006ab9a329709cbe...`

This fact carries no verifying quote; its source is the dataset named above.

The value

{
 "ingredient": "DAPAGLIFLOZIN",
 "recruitingInterventionalCount": 98,
 "notYetRecruitingCount": 45,
 "byPhase": {
  "PHASE4": 32,
  "PHASE3": 28,
  "EARLY_PHASE1": 1,
  "PHASE2": 18,
  "NA": 10,
  "PHASE2/PHASE3": 4,
  "PHASE1": 4,
  "PHASE1/PHASE2": 1
 },
 "trials": [
  {
   "nctId": "NCT07323524",
   "briefTitle": "Dapagliflozin in Active Lupus Nephritis",
   "phase": [
    "PHASE4"
   ],
   "leadSponsor": "Brigham and Women's Hospital",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-11-06",
   "startDate": "2026-05-22",
   "conditions": [
    "Lupus Nephritis (LN)"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07323524"
  },
  {
   "nctId": "NCT06742723",
   "briefTitle": "A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure",
   "phase": [
    "PHASE3"
   ],
   "leadSponsor": "AstraZeneca",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-11-06",
   "startDate": "2025-03-03",
   "conditions": [
    "Chronic Kidney Disease and Hypertension"
   ],
   "countries": [
    "United States",
    "Argentina",
    "Australia",
    "Belgium",
    "Brazil",
    "Bulgaria",
    "Canada",
    "Chile",
    "China",
    "Colombia"
   ],
   "url": "https://clinicaltrials.gov/study/NCT06742723"
  },
  {
   "nctId": "NCT07235280",
   "briefTitle": "Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma",
   "phase": [
    "EARLY_PHASE1"
   ],
   "leadSponsor": "Jonsson Comprehensive Cancer Center",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-11-05",
   "startDate": "2025-12-02",
   "conditions": [
    "Lung Adenocarcinoma",
    "Stage IA1 Lung Cancer American Joint Committee on Cancer (AJCC) v8",
    "Stage IA2 Lung Cancer AJCC v8"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07235280"
  },
  {
   "nctId": "NCT07351643",
   "briefTitle": "CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes Patients With Stage 4 CKM Syndrome",
   "phase": [
    "PHASE4"
   ],
   "leadSponsor": "Shenyang Northern Hospital",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-30",
   "startDate": "2026-06-25",
   "conditions": [
    "ACS (Acute Coronary Syndrome)",
    "SGLT2 Inhibitors"
   ],
   "countries": [
    "China"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07351643"
  },
  {
   "nctId": "NCT07662109",
   "briefTitle": "A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus",
   "phase": [
    "PHASE3"
   ],
   "leadSponsor": "AstraZeneca",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-30",
   "startDate": "2026-07-06",
   "conditions": [
    "Type 2 Diabetes Mellitus"
   ],
   "countries": [
    "United States",
    "Argentina",
    "Brazil",
    "China",
    "Czechia",
    "Denmark",
    "Germany",
    "Greece",
    "Hungary",
    "India"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07662109"
  },
  {
   "nctId": "NCT07310433",
   "briefTitle": "Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer",
   "phase": [
    "PHASE2"
   ],
   "leadSponsor": "Yung NA",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-28",
   "startDate": "2026-05-01",
   "conditions": [
    "Prostate Cancer",
    "Metastatic Prostate Cancer"
   ],
   "countries": [
    "China"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07310433"
  },
  {
   "nctId": "NCT06281899",
   "briefTitle": "Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus",
   "phase": [
    "PHASE4"
   ],
   "leadSponsor": "Anemia Working Group Romania",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-28",
   "startDate": "2022-01-01",
   "conditions": [
    "Chronic Kidney Diseases",
    "Type 2 Diabetes Mellitus"
   ],
   "countries": [
    "Romania"
   ],
   "url": "https://clinicaltrials.gov/study/NCT06281899"
  },
  {
   "nctId": "NCT06668389",
   "briefTitle": "Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial",
   "phase": [
    "PHASE4"
   ],
   "leadSponsor": "The University of Hong Kong",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-28",
   "startDate": "2025-05-12",
   "conditions": [
    "Congenital Heart Disease",
    "Repaired Tetralogy of Fallot (rTOF)",
    "Pulmonary Regurgitation"
   ],
   "countries": [
    "Hong Kong"
   ],
   "url": "https://clinicaltrials.gov/study/NCT06668389"
  },
  {
   "nctId": "NCT07569640",
   "briefTitle": "HFrEF Polypill in Sri Lanka RCT",
   "phase": [
    "PHASE3"
   ],
   "leadSponsor": "Washington University School of Medicine",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-22",
   "startDate": "2026-08-17",
   "conditions": [
    "Heart Failure With Reduced Ejection Fraction"
   ],
   "countries": [
    "Sri Lanka"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07569640"
  },
  {
   "nctId": "NCT06677060",
   "briefTitle": "Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin",
   "phase": [
    "PHASE3"
   ],
   "leadSponsor": "AstraZeneca",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-21",
   "startDate": "2025-03-14",
   "conditions": [
    "Heart Failure"
   ],
   "countries": [
    "United States",
    "Argentina",
    "Australia",
    "Brazil",
    "Bulgaria",
    "Canada",
    "China",
    "Czechia",
    "Denmark",
    "France"
   ],
   "url": "https://clin
... (shortened here; the full value is in the JSON twin)

SHA-256 of the exact stored value: 1a1cae24d9772dcfccae19d34544b41ce47faeac9e69a0e5cdbac29e5219eab1.

This fact as data (JSON) · Check an answer against its receipt · Licence

Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.